Joel Picus is currently working in Division of Medical Oncology, Department of Medicine,China. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
|
Adenocarcinoma, Adult; Antimetabolites, Antineoplastic /adverse effects, Antineoplastic Combined Chemotherapy Protocols /adverse effects, Follow-Up Studies; Granulocyte Colony-Stimulating Factor, Neoadjuvant Therapy, Pancreatic Neoplasms, Registries; Survival Analysis, United States |